Results 81 to 90 of about 8,118 (161)

Haematologic responses to primaquine used for radical cure of Plasmodium vivax in public health facilities in Ethiopia: a prospective observational study. [PDF]

Malar J
Shifraw T, Abdelmenan S, Zewde A, Worku A, Abera A, Mohammed H, Etana K, Keating J, Chibsa S, Girma S, Teka H, Mumba P, Murphy M, Karmarkar E, Price RN, Hwang J, Berhane Y.   +16 more
europepmc   +1 more source

Agent-based simulation of seasonal malaria chemoprevention strategy in Southern Tanzania: comparing dihydroartemisinin-piperaquine with or without primaquine. [PDF]

Malar J
Mfala CT, Nyambo DG, Mwaiswelo RO, Tchuenche JM, Clemen T.   +4 more
europepmc   +1 more source

Primaquine-Induced Methemoglobinemia: A Case Report. [PDF]

Cureus
Leite Cruz R, Vieira CB, Silva P, Pereira R, Germano N.   +4 more
europepmc   +1 more source

Antimalarial cabamiquine inhibits blood-stage of different field isolates of Plasmodium species. [PDF]

BMC Infect Dis
Dembele L, Aniweh Y, Soulama A, Sogore F, Diakité O, Diallo F, Dao F, Amenga-Etego LN, Demarta-Gatsi C, Spangenberg T, Djimde AA.   +10 more
europepmc   +1 more source

Predicting Risk of Plasmodium Vivax Microscopy-Detected Episodes Using Serological Markers in Patients With Plasmodium falciparum Malaria: A Multicountry Diagnostic Performance Evaluation. [PDF]

J Infect Dis
Hafidzah M, Degaga TS, Christian M, Alam MS, Hossain MS, Baird JK, Baird JK, Sutano I, Smith L, Argyropoulos DC, Amelia AR, Noviyanti R, Robinson LJ, Price RN, Mueller I, Thriemer K, Longley RJ.   +16 more
europepmc   +1 more source

A six-pronged approach to manage a Plasmodium vivax outbreak in a low- and middle-income country on the road to malaria elimination. [PDF]

PLoS Negl Trop Dis
Labadie-Bracho M, Baldewsingh GK, Hiwat van Laar H, Adhin MR.   +3 more
europepmc   +1 more source

Automated reporting of primaquine dose efficacy, tolerability and safety for Plasmodium vivax malaria using a systematic review and individual patient data meta-analysis. [PDF]

Malar J
Edler P, Rajasekhar M, Price DJ, Adam I, Awab GR, Barber BE, Brasil LW, Chamma-Siqueira NN, Chu CS, Cui L, Daher A, Gomes MDSM, Gonzalez-Ceron L, Grigg MJ, Karunajeewa H, Lacerda MVG, Ladeia-Andrade S, Leslie T, Ley B, Lidia K, Llanos-Cuentas A, Longley RJ, Manning L, Mekonnen DA, Monteiro WM, Moore BR, Nosten F, Pasaribu AP, Pereira DB, Poespoprodjo JR, Pukrittayakamee S, Rijal KR, Saravu K, Siqueira AM, Sutanto I, Taylor WRJ, Thanh PV, Thriemer K, Vieira JLF, White NJ, Yeshiwondim AK, Zuluaga-Idarraga LM, Guerin PJ, Simpson JA, Price RN, Commons RJ, WorldWide Antimalarial Resistance Network (WWARN) Vivax Primaquine Dosing Efficacy, Tolerability and Safety Study Group.   +47 more
europepmc   +1 more source

Glucose-6-phosphate dehydrogenase variants in Kachin, Myanmar. [PDF]

Parasites Hosts Dis
Moon Z, Aung JM, VanBik D, Yun HS, Lee S, Dinzouna-Boutamba SD, Ring Z, Hong Y, Chung DI, Goo YK.   +9 more
europepmc   +1 more source

<i>Plasmodium vivax</i> Malaria Relapse Risk Depends on Transmission Intensity: Evidence From a Longitudinal Study in Northwest Thailand. [PDF]

Open Forum Infect Dis
Chu CS, Lwin KM, Burgoine K, Phyo AP, Turner C, San T, Aung AA, Win HH, Htoo K, Soe NL, Christina N, Than HH, Dah N, Pilaseng K, Wiladpaingern J, Proux S, Mukaka M, Parker DM, Carrara VI, Nosten F, White NJ.   +20 more
europepmc   +1 more source

Effectiveness of tafenoquine and primaquine for radical cure of Plasmodium vivax: a meeting report from dissemination of results of the EFFORT trial to stakeholders in Pakistan. [PDF]

Malar J
Qurashi B, Zaidi SE, Mushtaque M, Faisal A, Haroon Z, Agha B, Hammal N, Hameed A, Raza A, Ali U, Khan A, Jabbar FA, Adam ZR, Mehmood T, Price RN, Ghanchi N, Thriemer K, Beg MA.   +17 more
europepmc   +1 more source